Search Results 1761-1770 of 21522 for platelets

1. Lenalidomide and AT-101 in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia - Mayo Clinic

   Platelet count ≥ 30,000/mm^3; Serum creatinine ≤ 1.5 x upper limit of normal (ULN); Total bilirubin ≤ 1.5 mg/dL or direct bilirubin ≤ 1.0mg/dL for ...

2. Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary - Mayo Clinic

   Platelet count ≥ 100,000/uL; Total bilirubin ≤ upper limits of normal (ULN); if liver metastases are present, total bilirubin ≤ 2 x ULN; Aspartate ...

3. Naveen L. Pereira, M.D. - Doctors and Medical Staff - Mayo Clinic

   He is the overall Principal Investigator of the international multi-center clinical trial, TAILOR PCI that is evaluating the individualization of anti-platelet ...

4. Physical Medicine and Rehabilitation News - Medical Professionals - Mayo Clinic

   Analyzing the performance of platelet ... Case study: Use of platelet-rich plasma and bone marrow aspirate concentrate injections to treat knee osteoarthritis.

5. Gene Therapy and Radioactive Iodine in Treating Patients with Locally Recurrent Prostate Cancer that Did Not Respond to External-Beam Radiation Therapy - Mayo Clinic

   No known CNS metastases. No prostate size > 140 cc. PATIENT CHARACTERISTICS: ECOG performance status 0-2; Life expectancy ≥ 12 weeks; ANC ≥ 1,500/μL; Platelet ...

6. MART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by Surgery - Mayo Clinic

   Platelets (PLT) ≥ 50,000 mL; Aspartate aminotransferase (AST) ≤ 3 x upper limit of normal (ULN); Alkaline phosphatase ≤ 3 x ULN; Ability to provide informed ...

7. Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors - Mayo Clinic

   Platelets ≥ 100,000/mm3 (≥ 100 GI/L) without transfusion within 2 weeks before screening laboratory sample collection. For subjects with HCC ≥ 75,000/mm3 ...

8. A Study to Evaluate Trifluridine/Tipiracil in Combination with Irinotecan to Treat Biliary Tract Cancers - Mayo Clinic

   Platelet count ≥ 100,000/mm3;; Total bilirubin ≤ 1.5 × upper limit of normal (ULN);; spartate transaminase (AST) or alanine transaminase (ALT) ≤ × ULN ...

9. Laminar LAAX Pivotal IDE Study - Mayo Clinic

   Persistent thrombocytopenia (platelet count \<75,000 cells/mm3), thrombocytosis (\>700,000 cells/mm3), or leukopenia (white blood cell count \<3,000 cells/mm3).

10. Coronary Angiogram Clinical Trials - Mayo Clinic Research

    ... Platelet) agents. In addition to exploring ED treatment patterns and success of both ischemic and bleeding risk stratification prior to definition of the ...